Transatlantique Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,555
Closed -$211K 217
2025
Q2
$211K Hold
4,555
0.08% 207
2025
Q1
$278K Sell
4,555
-5,577
-55% -$325K 0.11% 191
2024
Q4
$573K Sell
10,132
-4,600
-31% -$257K 0.22% 130
2024
Q3
$762K Sell
14,732
-4,664
-24% -$219K 0.29% 106
2024
Q2
$800K Sell
19,396
-5,124
-21% -$229K 0.33% 88
2024
Q1
$1.33M Buy
24,520
+6,235
+34% +$318K 0.58% 53
2023
Q4
$938K Sell
18,285
-1,088
-6% -$57.1K 0.44% 76
2023
Q3
$1.12M Hold
19,373
0.6% 47
2023
Q2
$1.24M Buy
19,373
+746
+4% +$50K 0.65% 45
2023
Q1
$1.29M Buy
18,627
+1,665
+10% +$117K 0.71% 36
2022
Q4
$1.22M Buy
16,962
+65
+0.4% +$4.9K 0.73% 36
2022
Q3
$1.2M Buy
16,897
+2,479
+17% +$180K 0.8% 34
2022
Q2
$1.11M Buy
+14,418
New +$1.1M 0.77% 33

Other funds holding BMY

Transatlantique Private Wealth's BMY Position: Q3 2025 in Review

Transatlantique Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 4,555 shares — an estimated $211K sold.

Transatlantique Private Wealth first reported a position in BMY in Q2 2022 and held it in 13 quarters. The position peaked at $1.33M in Q1 2024. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Transatlantique Private Wealth reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Transatlantique Private Wealth sold 4,555 Bristol-Myers Squibb shares in Q3 2025, an estimated $211K.
  • Transatlantique Private Wealth first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 13 quarters.
  • Transatlantique Private Wealth's Bristol-Myers Squibb position peaked at $1.33M in Q1 2024.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Transatlantique Private Wealth's 13F filing for Q3 2025, filed 10 Nov 2025.